Secretion of proinflammatory cytokines by normal human melanocytes in response to lipopolysaccharide

• Autorzy: Tam I. , Stepien K.
• Języki publikacji: EN

Abstrakty

EN

A large body of evidence suggests that epidermal melanocytes are an integral part of the skin immune system and can be considered immunocompetent cells. Recently, it has been reported that human melanocytes constitutively express Toll-like receptors and may be involved in the induction of several inflammatory cytokines. In the study the secretion of IL-1β, IL-6 and TNF-α by cultured normal melanocytes was investigated after stimulation with lipopolysaccharide. LPS increased the secretion of IL-1β in a dose-dependent manner. IL-1β stimulated release of IL-6 and TNF-α by melanocytes, whereas LPS activated production of TNF-α, but not of IL-6. These observations indicate that LPS can participate in the regulation of cytokine activity in normal human melanocytes and suggest that cytokines released by melanocytes could affect melanocytes themselves or/and other cells of the epidermis.

Słowa kluczowe

EN

secretion; proinflammatory cytokine; man; melanocyte; lipopolysaccharide; epidermal melanocyte; skin; immune system; adrenocorticotrophic hormone; ELISA test; interferon; interleukin; lactate dehydrogenase; polymerase chain reaction; tumour necrosis factor; toll-like receptor

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2011
• Tom: 58
• Numer: 4
• Opis fizyczny: p.507-511,fig.,ref.

Twórcy

autor

Tam I.

• Department of Instrumental Analysis, Medical University of Silesia, Sosnowiec, Poland

autor

Stepien K.

Bibliografia

• Abdel-Malek Z, Kadekaro A (2006) Human pigmentation: its regulation by ultraviolet light and by endocrine, paracrine, and autocrine factors. In The Pigmentary System: Physiology and Pathophysiology - 2nd edn. Nordlund J, Boissy R, Hearing V, King R, Oetting W, Ortonne J, eds, pp 410-420. Blackwell Publishing Ltd, Oxford, UK.
• Ahn J, Park T, Jin S, Kang H (2008a) Human melanocytes express functional Toll-like receptor 4. Exp Dermatol 17: 412-417. 
• Ahn J, Jin S, Kang H (2008b) LPS induces melanogenesis through p38 MAPK activation in human melanocytes. Arch Dermatol Res 300: 325-329. 
• Brajac I, Kaštelan M, Prpič-Massari L, Periša D, Lončarek K, Malnar D (2009) Melanocyte as a possible key cell in the pathogenesis of psoriasis vulgaris. Med Hypotheses 73: 254-256. 
• Brzoska T, Luger T, Maaser C, Abels C, Bohm M (2008) α-Melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29: 581-602. 
• Burbach G, Ansel J, Amstrong Ch (2001) Cytokines in the skin. In The Biology of the Skin. Freinkel R, Woodley D, eds, pp 299-332. The Parthenon Publishing, New York, USA.
• Clark J (2001) Role of cytokines in pathology of melanoma and use of biologic response modifiers in melanoma. In Methods in Molecular Medicine, Melanoma Techniques and Protocols: Molecular Diagnosis, Treatment, and Monitoring. Nickoloff B, Hood L, eds, pp 241-267. Humana Press, New Jersey, USA.
• Dayer J (2002) Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra. Clin Exp Rheumatol 20: S14-S20. 
• Elias E, Hasskamp J, Sharma B (2010) Cytokines and growth factors expressed by human cutaneous melanoma. Cancers 2: 794-808.
• Hari A, Flach T, Shi Y, Mydlarski R (2010) Toll-like receptors: role in dermatological disease. Mediators Inflamm 2010: 1-16. 
• Hasegawa J, Goto Y, Murata H, Takata M, Saida T, Imokawa G (2008) Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin. Pigment Cell Melanoma Res 21: 687-699. 
• Herrling T, Jung K, Fuchs J (2008) The role of melanin as protector against free radicals in skin and its role as free radical indicator in hair. Spectrochim Acta Part A Mol Biomol Spectrosc 69: 1429-1435. 
• Imokawa G (2006) Paracrine interactions of melanocytes in pigmentary disorders. In The Pigmentary System: Physiology and Pathophysiology - 2nd edn. Nordlund J, Boissy R, Hearing V, King R, Oetting W, Ortonne J, eds, pp 421-444. Blackwell Publishing Ltd, Oxford, UK.
• Jin H, Kang H (2010) Activation of toll-like receptors 1, 2, 4, 5, and 7 on human melanocytes modulate pigmentation. Ann Dermatol 22: 486-489. 
• Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E (2010) Interleukins 1α and 1β secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocytes differentiation antigens. Int J Cancer 127: 1625-1636. 
• Kozłowska K, Zarzeczna M, Cichorek M (2001) Characterization of NO and cytokine release by transplantable melanoma cell lines in relationship to their differentiation. Arch Immunol Ther Exp (Warsz.) 49: S103-S109. 
• Lázár-Molnár E, Hegyesi H, Tóth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12: 547-554. 
• Lu Y, Zhu W, Tan C, Yu G, Gu J (2002) Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Pigment Cell Res 15: 454-460. 
• Mackintosh J (2001) The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol 211: 101-113. 
• Mattei S, Colombo M, Melani C, Silvani A, Parmiani G, Herlyn M (1994) Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 56: 853-857. 
• Mohagheghpour N, Waleh N, Garger S, Dousman L, Grill L, Tusé D (2000) Synthetic melanin suppresses production of proinflammatory cytokines. Cell Immunol 199: 25-36. 
• Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P (2002) New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 15: 87-92. 
• Pandya A, Guevara I (2000) Disorders of hyperpigmentation. Dermatol Clin 18: 91-98. 
• Plonka P, Passeron T, Brenner M, Tobin D, Shibahara S, Thomas A, Slominski A, Kadekaro A, Hershkovitz D, Peters E, Nordlund J, Abdel-Malek Z, Takeda K, Paus R, Ortonne J, Hearing V, Schallreuter K (2009) What are melanocytes really doing all day long...?. Exp Dermatol 18: 799-819. 
• Radtke S, Wüller S, Yang X, Lippok B, Mütze B, Mais C, Schmitz-Van de Leur H, Bode J, Gaestel M, Heinrich P, Behrmann I, Schaper F, Hermanns H (2010) Cross-regulation of cytokine signalling pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J Cell Sci 123: 947-959. 
• Romero-Graillet C, Aberdam E, Clement M, Ortonne J, Ballotti R (1997) Nitric oxide produced by ultraviolet irradiated keratinocytes stimulates melanogenesis. J Clin Invest 99: 635-642. 
• Sasaki M, Horikoshi T, Uchiwa H, Miyachi Y (2000) Up-regulation of tyrosinase gene by nitric oxide in human melanocytes. Pigment Cell Res 13: 248-252. 
• Shang J, Eberle J, Geilen C, Hossini A, Fecker L, Orfanos C, Tebbe B (2002) The role of nuclear factor-kappaB and melanogenesis in tumor necrosis factor-alpha-induced apoptosis of normal human melanocytes. Skin Pharmacol Appl Skin Physiol 15: 321-329. 
• Slominski A (2009) Neuroendocrine activity of the melanocytes. Exp Dermatol 18: 760-763. 
• Slominski A, Goodman-Snitkoff G (1992) Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res 12: 753-756. 
• Slominski A, Paus R, Mihm M (1998) Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 18: 3709-3716. 
• Slominski A, Gomez-Sanchez C, Foecking M, Wortsman J (1999) Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cell. FEBS Lett 455: 364-366. 
• Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000) Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80: 979-1020. 
• Slominski A, Tobin D, Shibahara S, Wortsman J (2004a) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84: 1155-1228. 
• Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, Sweatman T, Marcos J, Dunbar C, Tuckey R (2004b) A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem 271: 4178-4188. 
• Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, Wortsman J (2005) CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab 288: E701-E706. 
• Slominski A, Zbytek B, Slominski R (2009) Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer 124: 1470-1477. 
• Smit N, Le Poole I, van den Wijngaard R, Tigges A, Westerhof W, Das P (1993) Expression of different immunological markers by cultured human melanocytes. Arch Dermatol Res 285: 356-365. 
• Stępień K (2010) The role of melanocytes in protection against photooxidative stress. Postepy Biochem 56: 290-297. 
• Swope V, Abdel-Malek Z, Kassem L, Nordlund J (1991) Interleukins 1 α and 6 and tumor necrosis factor -α are paracrine inhibitors of human melanocytes proliferation and melanogenesis. J Invest Dermatol 96: 180-185. 
• Swope V, Sauder D, McKenzie R, Sramkoski R, Krug K, Babcock G, Nordlund J, Abdel-Malek Z (1994) Synthesis of interleukin-1α and β by normal human melanocytes. J Invest Dermatol 102: 749-753. 
• Tam I, Stępień K (2007) Melanocytes - immunocompetent pigmented cells. Post Dermatol Alergol 24: 188-193.
• Van der Meer JW, Helle M, Aarden L (2005) Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection. Eur J Immunol 19: 413-416. 
• Verstrepen L, Bekaert T, Chau T, Tavernier J, Chariot A, Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell Mol Life Sci 65: 2964-2978. 
• Yu N, Zhang S, Zuo F, Kang K, Guan M, Xiang L (2009) Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9. J Dermatol Sci 56: 113-120